Bayer AG (BAYN.DE)
-XETRA 85.50 
0.85(1.00%) 11:35AM EDT
| Prev Close: | 84.65 |
|---|
| Open: | 84.18 |
|---|
| Bid: | 85.48 |
|---|
| Ask: | 85.53 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 84.18 - 85.64 |
|---|
| 52wk Range: | 47.63 - 85.67 |
|---|
| Volume: | 2,234,179 |
|---|
| Avg Vol (3m): | 2,200,380 |
|---|
| Market Cap: | 70.70B |
|---|
| P/E (ttm): | 27.57 |
|---|
| EPS (ttm): | 3.10 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in EUR.
Headlines
- Deutsche Bank Seeks to Avoid Law Suits With Board Changesat Bloomberg(Tue, May 21)
- Regeneron, Sanofi asthma drug seen as potential game changerat Reuters(Tue, May 21)
- German stocks - Factors to watch on May 21at Reuters(Tue, May 21)
- Regeneron settles all pending litigation with Roche's Genentechat Reuters(Mon, May 20)
- Bayer says lung drug shows promise in prolonged trialat Reuters(Mon, May 20)
- EU watchdog backs Bayer acne drug for certain patientsat Reuters(Fri, May 17)
- [$$] Dow Chemical to Appeal Judgmentat The Wall Street Journal(Thu, May 16)
- Bayer to acquire herbal medicine maker Steigerwaldat Reuters(Thu, May 16)
- Algeta Surges to Record After Prostate Cancer Drug Approvalat Bloomberg(Thu, May 16)
- German stocks - Factors to watch on May 16at Reuters(Thu, May 16)
- NORDIC STOCKS - Factors to watch on May 16at Reuters(Thu, May 16)
- [$$] Bayer Gets FDA Approval for Advanced Prostate Cancer Drugat The Wall Street Journal(Wed, May 15)
- Bayer, Algeta win FDA approval for prostate cancer drugat Reuters(Wed, May 15)
- Bayer, Algeta Win U.S. Approval for Prostate Cancer Drugat Bloomberg(Wed, May 15)
- German chemical sector still sees 2 pct growth in 2013at Reuters(Wed, May 15)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 1.75 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Bayer Aktiengesellschaft develops, produces, and markets health care and agriculture products, and high-tech materials worldwide. The companys HealthCare segment provides pharmaceuticals, such as prescription pharmaceuticals for the treatmen...
View More